Liquidia Stock (LQDA) Pops as $380.7M Deal Ends Legal Battle with United Therapeutics
Liquidia ($LQDA) stock jumped about 47% in Wednesday’s pre-market trading after the biopharmaceutical company focused on respiratory and vascular d...
United Therapeutics Corp (UTHR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 2,777,777 | $1,505,082,912 | +6% | 13.52% |
| 2. | Renaissance Technologies Jim Simons | 1,708,739 | $925,846,052 | -5% | 1.27% |
| 3. | AQR Capital Management Cliff Asness | 546,002 | $294,639,029 | -34% | 0.1% |
| 4. | Deerfield Management James E. Flynn | 457,000 | $247,616,310 | 2.58% | |
| 5. | Vestal Point Capital Ryan Wilder | 435,000 | $235,696,050 | +480% | 5.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $575.96 | 1,500 | $863,947.35 | 43,153 | 2026-05-26 | Filing | |
| $82.83 | 4 | $331.32 | 1,684 | 2019-06-10 | Filing | |
| $114.06 | 6 | $684.36 | 1,686 | 2018-04-20 | Filing | |
| $126.20 | 5 | $631.00 | 1,685 | 2017-11-20 | Filing | |
| $128.35 | 3 | $385.05 | 1,686 | 2017-07-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $551.50 | 120 | $66,180.00 | 324,443 | 2026-10-15 | Filing | |
| $550.72 | 200 | $110,143.20 | 324,563 | 2026-10-15 | Filing | |
| $549.76 | 1,009 | $554,703.80 | 324,763 | 2026-10-15 | Filing | |
| $548.89 | 2,039 | $1,119,183.04 | 325,772 | 2026-10-15 | Filing | |
| $547.83 | 2,166 | $1,186,592.85 | 327,811 | 2026-10-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 70,287 | $38,087,822 | 0.04% | |
| 2. | 60,976 | $33,042,105 | 1.7% | |
| 3. | 36,538 | $19,799,577 | 0.1% | |
| 4. | 30,336 | $16,438,775 | 5.18% | |
| 5. | 20,003 | $10,839,426 | 6.47% |
News See All
United Therapeutics (UTHR): Goldman Says Sell As The Base Business Shrinks, But 2027 Holds Real Catalysts
Goldman Sachs analyst Andrea Newkirk initiated coverage of United Therapeutics Corporation (NASDAQ:UTHR) on September 24, 2026, with a Sell rating and a $321 price target.
These 3 ETFs Could Deliver Over 12% Upside, According to the AI Analyst
TipRanks’ ETF AI Analyst rates the State Street SPDR Portfolio S&P 500 ETF ($SPYM), Financial Select Sector SPDR Fund ($XLF), and Vanguard S&P Mid-...
United Therapeutics (UTHR) Sets $477.6 Million Buyback. Can Pipeline Funding Keep Pace?
United Therapeutics Corporation (NASDAQ:UTHR) committed the remaining $477.6 million under its $2 billion authorization to an accelerated share repurchase with Citibank, N.A. on September 8.
3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy
We are diving into three healthcare stocks which all have a Strong Buy consensus and a 10 out of 10 TipRanks Smart Score. The Smart Score is a prop...
Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation?
We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. United Therapeutics Corporation (NASDAQ:UTHR) is one of the best healthcare stocks on our list.
10 Best Innovative Healthcare Stocks to Buy Now
In this article, we will be taking a look at the 10 Best Innovative Healthcare Stocks to Buy Now. The U.S.
12 Best Stocks to Invest In According to Jim Simons' Renaissance Technologies
In this article, we discuss the 12 Best Stocks to Invest In According to Jim Simons' Renaissance Technologies.
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2026 Earnings Call Transcript
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2026 Earnings Call Transcript May 6, 2026United Therapeutics Corporation misses on earnings expectations.
15 Set-It-and-Forget-It Stocks to Buy in 2026
In this article, we will take a look at the 15 Set-It-and-Forget-It Stocks to Buy in 2026. Long-term wealth building requires choosing investments that could withstand various economic conditions.
Hedge Fund Resource Center